Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 96T |
|---|---|
| Brand | ProteoGenix |
| Product type | Elisa assay kits |
| Product name | EEEV Spike glycoprotein E2 ELISA Kit |
|---|---|
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stocks, 3-5 weeks if production is needed |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Brand | ProteoGenix |
| Note | For research use only. |
| Immunogen | Spike glycoprotein E2 |
| Assay type | Quantitative |
| Detection method | Colorimetric |
| Recovery | 80-120% |
The Eastern equine encephalitis virus (EEEV) is a mosquito-borne virus that can cause severe neurological disease in humans and horses. The virus is primarily found in the eastern regions of North America, but has also been reported in other parts of the world. The spike glycoprotein E2 of EEEV is a key component of the virus that plays a crucial role in its structure, activity and pathogenesis. The EEEV Spike glycoprotein E2 ELISA Kit is a valuable tool for researchers studying this virus and its potential as a therapeutic target.
The EEEV Spike glycoprotein E2 is a type I transmembrane protein that is composed of 423 amino acids. It is a part of the viral envelope and is responsible for mediating the attachment and entry of the virus into host cells. The E2 protein is highly glycosylated, meaning it has many sugar molecules attached to it, which helps in shielding the virus from the host immune system.
The E2 protein is made up of three distinct domains: the N-terminal domain, the central domain, and the C-terminal domain. The N-terminal domain is responsible for binding to host cell receptors, while the central domain is involved in viral fusion and entry. The C-terminal domain is responsible for stabilizing the protein and maintaining its structure.
The E2 protein plays a crucial role in the pathogenesis of EEEV. It is responsible for the attachment of the virus to host cells, which is the first step in the infection process. The E2 protein binds to specific receptors on the surface of host cells, allowing the virus to enter and replicate within the cell.
In addition to its role in viral entry, the E2 protein also plays a role in the evasion of the host immune response. The high level of glycosylation on the E2 protein helps in masking the virus from the host’s immune system, allowing it to evade detection and continue to replicate.
The EEEV Spike glycoprotein E2 ELISA Kit is a valuable tool for researchers studying EEEV and its potential as a therapeutic target. The kit allows for the detection and quantification of E2 protein in samples, providing valuable information about the viral load and its activity.
The EEEV Spike glycoprotein E2 ELISA Kit can also be used to study the interaction of the E2 protein with host cell receptors, providing insights into the mechanisms of viral entry and potential targets for antiviral therapies.
Furthermore, the EEEV Spike glycoprotein E2 ELISA Kit can be used to screen potential antiviral compounds and assess their effectiveness in blocking the activity of the E2 protein. This can aid in the development of novel therapeutics for EEEV infection.
In conclusion, the EEEV Spike glycoprotein E2 ELISA Kit is a valuable tool for researchers studying the structure, activity, and potential therapeutic targeting of the E2 protein in EEEV. Its ability to detect and quantify the protein in samples makes it an essential tool for understanding the pathogenesis of this virus and developing effective treatments. Further research using this kit may lead to the development of new antiviral therapies for EEEV infection.
Send us a message from the form below
Reviews
There are no reviews yet.